Clinical Trial Update: S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 SWOG trial S0501 evaluating fludarabine, melphalan, and donor stem cell transplantation followed by tacrolimus and methotrexate for relapsed lymphoma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Alkeran (melphalan)
• Fludara (fludarabine)
• Prograf (Tacrolimus)
• Rheumatrex (methotrexate)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2012-04-03